Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding

A Olagunju, A Owen, TR Cressey - Pharmacogenomics, 2012 - Taylor & Francis
Mother-to-child-transmission rates of HIV in the absence of any intervention range between
20 and 45%. However, the provision of antiretroviral drugs (ARVs) during pregnancy …

Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding

A Olagunju, A Owen, TR Cressey - 2012 - cmuir.cmu.ac.th
Mother-to-child-transmission rates of HIV in the absence of any intervention range between
20 and 45%. However, the provision of antiretroviral drugs (ARVs) during pregnancy …

Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding.

A Olagunju, A Owen, TR Cressey - Pharmacogenomics, 2012 - europepmc.org
Mother-to-child-transmission rates of HIV in the absence of any intervention range between
20 and 45%. However, the provision of antiretroviral drugs (ARVs) during pregnancy …

Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding

A Olagunju, A Owen, T Creesey - Pharmacogenomics, 2012 - hero.epa.gov
Mother-to-child-transmission rates of HIV in the absence of any intervention range between
20 and 45%. However, the provision of antiretroviral drugs (ARVs) during pregnancy …

Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding

A Olagunju, A Owen, TR Cressey - Pharmacogenomics, 2012 - go.gale.com
Mother-to-child-transmission (MTCT) rates of HIV without any intervention range between 20
and 45%[1]. An estimated 387,000 children were infected with HIV through MTCT in 2008 …

Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding

A Olagunju, A Owen, TR Cressey - Pharmacogenomics, 2012 - pubmed.ncbi.nlm.nih.gov
Mother-to-child-transmission rates of HIV in the absence of any intervention range between
20 and 45%. However, the provision of antiretroviral drugs (ARVs) during pregnancy …

Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding

A Olagunju, A Owen, TR Cressey - Pharmacogenomics, 2012 - search.proquest.com
Mother-to-child-transmission rates of HIV in the absence of any intervention range between
20 and 45%. However, the provision of antiretroviral drugs (ARVs) during pregnancy …